| | | | | | | Sponsored | | Join Bio-Rad’s community for lab professionals! Access curated resources, hands-on guides, and real-world case stories to enhance skills and streamline quality control workflows. |
|
|
|
| |
| | |
|
|
| | | | | | The Centers for Disease Control and Prevention (CDC) announced that they revised their adult and child immunization schedules. The updates were suggested by the Advisory Committee on Immunization Practices (ACIP) and approved by Jim O'Neill. |
|
|
| | MLO’s October CE is now live! Passing scores of 70 percent or higher are eligible for 1 contact hour of P.A.C.E. credit. |
|
|
|
| |
| | |
|
|
| | | | Sponsored | | The acquisition of Orchard Software by Clinisys marks a significant milestone in the laboratory informatics industry, promising accelerated innovation, broader solution offerings, and enhanced support for laboratories worldwide. The combined expertise and resources will help laboratories improve efficiency, compliance, and patient outcomes in an increasingly complex healthcare environment. |
|
|
|
| |
| | |
|
|
| | | | | | The World Health Organization (WHO) has published the sixth edition of their tobacco report, titled “WHO global report on trends in prevalence of tobacco use 2000–2024 and projections 2025–2030.” Key findings are summarized in a press release. |
|
|
|
| |
| | |
|
|
| | | | | | Updates to the approach pathologists use to classify myelodysplastic neoplasm (MDS), formally known as myelodysplastic syndrome, are expected to improve treatment decision-making for patients, according to a new publication by the College of American Pathologists (CAP). |
|
|
|
| |
| | |
|
|
| | | | Sponsored | | Unlock the future of pathology with AI-driven workflows that accelerate turnaround times, sharpen diagnostic precision, and enable collaboration across care teams. Gestalt’s PathFlow helps labs deliver faster, more accurate results, transforming decisions and improving outcomes with intelligent automation and connected insights. |
|
|
|
| |
| | |
|
|
| | | | | | Thermo Fisher Scientific has introduced a new laboratory developed test for post-transplant biopsy assessment designed to improve the detection of lung transplant rejection and injury, delivering quantifiable results that may increase diagnostic confidence and guide timely treatment. |
|
|
|
| |
| | |
|
|
| | |
|
| | |
|
